NASDAQ : LIVN
LivaNova PLC — Key statistics
Healthcare · Medical Devices · United Kingdom
Last price 78.97 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.35B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 4.35B |
| Enterprise Value | 4.19B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 55.09M |
| Shares Outstanding | 55.09M |
| Shares Change (YoY) | +1.77% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | 0.44% |
| Owned by Institutions (%) | 113.71% |
| Float | 54.84M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 23.21 |
| Forward PE | 17.61 |
| PS Ratio | 2.96 |
| Forward PS | 2.76 |
| PB Ratio | 3.28 |
| P/TBV Ratio | 13.22 |
| P/FCF Ratio | 29.34 |
| P/OCF Ratio | 17.45 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 22.20 |
| EV / Sales | 2.84 |
| EV / EBITDA | 16.09 |
| EV / EBIT | 20.17 |
| EV / FCF | 28.23 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.45 |
| Quick Ratio | 1.08 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 1.28 |
| Debt / FCF | 2.37 |
| Interest Coverage | 6.01 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 15.40% |
| Return on Assets (ROA) | 5.04% |
| Return on Invested Capital (ROIC) | 19.08% |
| Return on Capital Employed (ROCE) | 10.73% |
| Weighted Average Cost of Capital (WACC) | 9.20% |
| Revenue Per Employee | $445,915 |
| Profits Per Employee | $57,137 |
| Employee Count | 3,300 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 2.81 |
Taxes
| Measure | Value |
|---|
| Income Tax | -82.03M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.92 |
| 52-Week Price Change | +48.05% |
| 50-Day Moving Average | 78.49 |
| 200-Day Moving Average | 72.90 |
| Relative Strength Index (RSI) | 50.81 |
| Average Volume (20 Days) | 551,372 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 6.20M |
| Short Previous Month | 6.00M |
| Short % of Shares Out | 11.25% |
| Short % of Float | 11.31% |
| Short Ratio (days to cover) | 9.21 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.47B |
| Gross Profit | 996.85M |
| Operating Income | 207.55M |
| Pretax Income | 106.52M |
| Net Income | 188.55M |
| EBITDA | 260.14M |
| EBIT | 207.55M |
| Earnings Per Share (EPS) | $3.40 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 516.62M |
| Total Debt | 351.95M |
| Net Cash | 164.67M |
| Net Cash Per Share | $2.99 |
| Equity (Book Value) | 1.33B |
| Book Value Per Share | 24.07 |
| Working Capital | 318.04M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 249.26M |
| Capital Expenditures | -100.95M |
| Depreciation & Amortization | 52.59M |
| Net Borrowing | -166.62M |
| Free Cash Flow | 148.31M |
| FCF Per Share | $2.69 |
Margins
| Measure | Value |
|---|
| Gross Margin | 67.74% |
| Operating Margin | 14.10% |
| Pretax Margin | 7.24% |
| Profit Margin | 12.81% |
| EBITDA Margin | 17.68% |
| EBIT Margin | 14.10% |
| FCF Margin | 10.08% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.77% |
| Shareholder Yield | n/a |
| Earnings Yield | 4.31% |
| FCF Yield | 3.41% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $90.55 |
| Price Target Difference | 14.66% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 7.93% |
| EPS Growth Forecast (3Y) | 10.25% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.93 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |